Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Combination Product: ofatumumab with AI1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
2Combination Product: ofatumumab with PRF1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
3Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: D01370 ,
D02802 ,
D02994 ,
D03846 ,
D05218 ,
D06886 ,
D09314 (Name: Ofatumumab),
D10001 ,
D10172 ,
D11215 		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		-1件: 13
4OFATUMUMAB1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬3件: 13, 35, 46
5Ofatumumab 1001件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
6Ofatumumab 3001件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
7Ofatumumab 30mg1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
8Ofatumumab 3mg1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
9Ofatumumab 60mg1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
10Ofatumumab 7001件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13
11Ofatumumab subcutaneous injection1件: Ofatumumab1件: D09314 (Name: Ofatumumab)1件: MS4A1 💬1件: Hematopoietic cell lineage 💬1件: 13